-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Artelo Biosciences, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2017 to Q3 2025.
- Artelo Biosciences, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2025 was -$31K, a 149% decline year-over-year.
- Artelo Biosciences, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2025 was -$61K, a 115% decline year-over-year.
- Artelo Biosciences, Inc. annual Nonoperating Income (Expense) for 2024 was $282K, a 56% decline from 2023.
- Artelo Biosciences, Inc. annual Nonoperating Income (Expense) for 2023 was $641K, a 214% increase from 2022.
- Artelo Biosciences, Inc. annual Nonoperating Income (Expense) for 2022 was $204K, a 1940% increase from 2021.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)